Lemaitre Vascular (LMAT) Tops Q2 EPS by 2c, Revenues Beat; Offers Q3 & FY19 EPS/Revenue Guidance Above Consensus
Tweet Send to a Friend
Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.23, $0.02 better than the analyst estimate of $0.21. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
